Paper42823964PubMed
A biomaterials roadmap from retinoic acid biology to kidney regenerative therapy.
Tan RY and 9 others. iScience, 2026.
Cite this record
ConductScience Library. A biomaterials roadmap from retinoic acid biology to kidney regenerative therapy. Papers, record 42823964. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42823964
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A biomaterials roadmap from retinoic acid biology to kidney regenerative therapy.
- Journal
- iScience
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-10-03
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References117
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34183258 | Cell-based regenerative medicine for renovascular disease. | Trends Mol Med | 2021 | https://conductscience.org/library/papers/34183258 | PubMed |
| 2 | 40730917 | The kidney stroma in development and disease. | Nat Rev Nephrol | 2025 | https://conductscience.org/library/papers/40730917 | PubMed |
| 3 | 14694163 | Prevention of acute ischemic renal failure by targeted delivery of growth factors to the proximal tubule in transgenic mice: the efficacy of parathyroid hormone-related protein and hepatocyte growth factor. | J Am Soc Nephrol | 2004 | https://conductscience.org/library/papers/14694163 | PubMed |
| 4 | 34015278 | Fabrication of All-Trans Retinoic Acid loaded Chitosan/Tripolyphosphate Lipid Hybrid Nanoparticles as a Novel Oral Delivery Approach for Management of Diabetic Nephropathy in Rats. | J Pharm Sci | 2021 | https://conductscience.org/library/papers/34015278 | PubMed |
| 5 | 36915713 | Nanocarrier of Pin1 inhibitor based on supercritical fluid technology inhibits cancer metastasis by blocking multiple signaling pathways. | Regen Biomater | 2023 | https://conductscience.org/library/papers/36915713 | PubMed |
| 6 | 15567713 | Expression of retinoic acid-synthesizing and -metabolizing enzymes during nephrogenesis in the rat. | Gene Expr Patterns | 2004 | https://conductscience.org/library/papers/15567713 | PubMed |
| 7 | 36923529 | WT1+ glomerular parietal epithelial progenitors promote renal proximal tubule regeneration after severe acute kidney injury. | Theranostics | 2023 | https://conductscience.org/library/papers/36923529 | PubMed |
| 8 | 11807825 | Regulation of BMP-7 expression by retinoic acid and prostaglandin E(2). | J Cell Physiol | 2002 | https://conductscience.org/library/papers/11807825 | PubMed |
| 9 | 32302545 | Retinoic Acid Organizes the Zebrafish Vagus Motor Topographic Map via Spatiotemporal Coordination of Hgf/Met Signaling. | Dev Cell | 2020 | https://conductscience.org/library/papers/32302545 | PubMed |
| 10 | 38490518 | The involvement of the Wnt/β-catenin signaling cascade in fibrosis progression and its therapeutic targeting by relaxin. | Biochem Pharmacol | 2024 | https://conductscience.org/library/papers/38490518 | PubMed |
| 11 | 39242924 | Astrocytic RARγ mediates hippocampal astrocytosis and neurogenesis deficits in chronic retinoic acid-induced depression. | Neuropsychopharmacology | 2024 | https://conductscience.org/library/papers/39242924 | PubMed |
| 12 | 35902874 | All-trans retinoic acid modulates pigmentation, neuroretinal maturation, and corneal transparency in human multiocular organoids. | Stem Cell Res Ther | 2022 | https://conductscience.org/library/papers/35902874 | PubMed |
| 13 | 23973508 | Effects of mycophenolic acid-glucosamine conjugates on the base of kidney targeted drug delivery. | Int J Pharm | 2013 | https://conductscience.org/library/papers/23973508 | PubMed |
| 14 | 39581798 | The activin-follistatin system: Key regulator of kidney development, regeneration, inflammation, and fibrosis. | Cytokine Growth Factor Rev | 2025 | https://conductscience.org/library/papers/39581798 | PubMed |
| 15 | 32168938 | Design, Synthesis, and Renal Targeting of Methylprednisolone-Lysozyme. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32168938 | PubMed |
| 16 | 37698919 | Inhibition of retinoic acid signaling in proximal tubular epithelial cells protects against acute kidney injury. | JCI Insight | 2023 | https://conductscience.org/library/papers/37698919 | PubMed |
| 17 | 29369015 | Developmental biology in bioartificial tissue design: manufacturing and regulatory considerations. | Regen Med | 2018 | https://conductscience.org/library/papers/29369015 | PubMed |
| 18 | 21761484 | Zebrafish nephrogenesis involves dynamic spatiotemporal expression changes in renal progenitors and essential signals from retinoic acid and irx3b. | Dev Dyn | 2011 | https://conductscience.org/library/papers/21761484 | PubMed |
| 19 | 32925167 | The yin and yang of retinoic acid signaling in kidney diseases. | J Clin Invest | 2020 | https://conductscience.org/library/papers/32925167 | PubMed |
| 20 | 39183263 | Extracellular vesicle therapy in neurological disorders. | J Biomed Sci | 2024 | https://conductscience.org/library/papers/39183263 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42823964
GET https://conductscience.org/api/papers/v1/42823964/references?page=2